搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
18 小时
on MSN
Pfizer’s Activist Battle Might Fizzle—but Its Stock Probably Won’t
The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.
2 天
Pfizer Q3 Preview: Why The Stock Is A Buy Ahead Of Earnings
Pfizer's Q3 consensus estimate is likely to be exceeded. Despite the underperformance over the past two months, see why PFE ...
BioSpace
1 天
Analysts Rally Around Pfizer CEO Amid Starboard Challenge
Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...
The Sunday Business Post
5 小时
Exclusive: Pfizer shutters 12 Irish firms with €600m of assets as part of major restructuring
The pharma powerhouse which employs about 5,000 workers across Ireland - at bases in Cork, Dublin and Kildare - has ...
6 天
Pfizer: Activists Clouding A Promising Picture
Pfizer's focus should remain on existing cost realignment plans and pipeline investments. Read why my investment thesis ...
FiercePharma
4 天
UPDATED: Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals ...
Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.
3 天
What activist hedge fund Starboard wants from Pfizer
Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO ...
FiercePharma
4 天
Pfizer lays off 75 more workers in North Carolina in wake of late-stage DMD trial fail
Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. | Pfizer has told 75 ...
12 天
on MSN
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
4 天
Activist Investor Starboard Slams Pfizer for Underperforming R&D And Overpaying for ...
Starboard Value criticizes Pfizer's leadership for underperformance, citing a 50% stock decline and missed growth targets ...
BioSpace
3 天
Pfizer Wins FDA Approval of RSV Vaccine for Broader Adult Population
Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age.
BioPharma Dive
3 天
Pfizer’s RSV vaccine cleared by FDA for use in some younger adults
Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈